Alerts will be sent to your verified email
Verify Email
ASPIRA
|
Aspira Pathlab&Diagn
|
NG Industries
|
Aatmaj Healthcare
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
-17.43 % | 23.44 % | 58.35 % |
|
5yr average Equity Multiplier
|
1.88 | 1.13 | 2.14 |
|
5yr Average Asset Turnover Ratio
|
0.94 | 0.81 | 1.04 |
|
5yr Avg Net Profit Margin
|
-7.87 % | 35.6 % | 18.45 % |
|
Price to Book
|
5.28 | 1.35 | 0.0 |
|
P/E
|
28.23 | 6.71 | 68.26 |
|
5yr Avg Cash Conversion Cycle
|
0.44 Days | 16.22 Days | 203.12 Days |
|
Inventory Days
|
9.76 Days | 22.11 Days | 6.98 Days |
|
Days Receivable
|
63.31 Days | 2.33 Days | 445.79 Days |
|
Days Payable
|
71.12 Days | 0.0 | 229.58 Days |
|
5yr Average Interest Coverage Ratio
|
1.38 | 50.93 | 13.18 |
|
5yr Avg ROCE
|
0.39 % | 20.04 % | 51.41 % |
|
5yr Avg Operating Profit Margin
|
7.15 % | 11.77 % | 29.38 % |
|
5 yr average Debt to Equity
|
0.49 | 0.08 | 0.73 |
|
5yr CAGR Net Profit
|
-8.83 % | n/a | -26.56 % |
|
5yr Average Return on Assets
|
-2.39 % | 21.18 % | 22.82 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
18.39 % | 74.5 % | 63.74 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-17.86 % | 0.0 | 0.02 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Aspira Pathlab&Diagn
|
NG Industries
|
Aatmaj Healthcare
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|